NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

MS Relapses During COVID-19 Pandemic

CompletedN/A

Sponsor: Nottingham University Hospitals NHS Trust

Conditions: Multiple Sclerosis, Covid19, Relapsing Remitting Multiple Sclerosis

Interventions: No Intervention

Countries: United Kingdom

Throughout the COVID-19 pandemic, and to our knowledge there have been no studies looking systematically at the occurrence of MS relapses and their subsequent management, during the peak of the first wave of the pandemic. In this study we will explore how MS relapses were reported and managed during April - June 2020, compared to a control cohort who experienced a relapse during the same period in 2019 across 5 UK centers.

Eligibility overview

Sex: ALL

Age: 16 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients with a confirmed diagnosis of MS or Clinically Isolated Syndrome (CIS) and
* Atleast one clinician confirmed probable relapse between 01/04/2020 and 30/06/2020 or 01/04/2019 and 30/06/2019

Exclusion Criteria:

* Age \<16 years

Locations (1)

Nottingham, United Kingdom